Drugs / Purified Verocell Rabies Vaccine
Purified Verocell Rabies Vaccine
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT01228383 | Dec 2011 → Oct 2012 | rabies | Crucell Holland BV | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT00260351 | Dec 2004 → Aug 2008 | rabies | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01148459 Comparator | Jul 2010 → May 2013 | malaria | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Purified Vero Cell Rabies Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01148459 ↗ |
| Known as | PVRV | “Human Diploid Cell Vaccine (HDCV) or Purified Vero Cell Rabies Vaccine (PVRV, Verorab) (Aventis Pasteur);” NCT01148459 ↗1“Purified verocell rabies vaccine (PVRV)” NCT01228383 ↗ |
| Known as | Verorab | “Human Diploid Cell Vaccine (HDCV) or Purified Vero Cell Rabies Vaccine (PVRV, Verorab) (Aventis Pasteur);” NCT01148459 ↗ |
| Modality | Vaccine | “rabies vaccine administered according to the Thai Red Cross” NCT00260351 ↗ |